Mourad Ferdaoussi, Ph.D.

Assistant Professor, Campus Saint-Jean - Soutien Académique

Contact

Assistant Professor, Campus Saint-Jean - Soutien Académique
Email
ferdaous@ualberta.ca
Address
3-09 CSJ Pavillon Lacerte
8406 Marie-Anne-Gaboury St (91 St)
Edmonton AB
T6C 4G9

Faculty of Medicine & Dentistry - Alberta Diabetes Research Institute
Phone
(780) 492-9475
Address
Lab 6-080 Li Ka Shing Centre For Research
8602 112 Street NW
Edmonton AB
T6G 2E1

Overview

Area of Study / Keywords

CSJ Researchers - Health Sciences CSJ chercheurs - Santé


About

Mourad Ferdaoussi is an Assistant Professor at Faculty Saint-Jean, the French Campus of the University of Alberta. He has a Ph.D. from the University of Lausanne, Switzerland, and an MSc from the University of Lille, France. His research focuses on understanding the cellular and molecular mechanisms regulating pancreatic beta cell function and survival in physiological and pathophysiological conditions related to type 2 diabetes. Besides, he has a growing interest in understanding the etiology of heart failure. Mourad Ferdaoussi has conducted postdoctoral research at the Montreal Diabetes Research Center and the Alberta Diabetes Institute. He has been a Research Associate at the Department of Pediatrics of the U of A. In addition to his research, Mourad is passionate about teaching and has taught 12 different courses related to biological and physiological sciences in the last five years. He is an academic member of the Alberta Diabetes Institute, the Canadian Islet Research and Training Network, and the University of Alberta Cardiovascular Research Institute. Mourad has received numerous awards, including the 2016 Med Star Postdoctoral and Clinical Fellows award from the Faculty of Medicine & Dentistry of the U of A and the 2008 Gabriel Baud award from the University of Lausanne, Switzerland. He has also published several articles on novel pre-clinical therapeutic approaches to tackle heart failure and systemic inflammation.


Research

The Ferdaoussi lab is dedicated to uncovering the root causes of pancreatic ß cell failure and death in type 2 Diabetes. We are also actively engaged in developing new molecules and peptides to safeguard pancreatic islets and stem-derived β cells during transplantation procedures. Furthermore, we are fully committed to fostering bilingual research in French-Canadian minority communities as part of our unwavering dedication to equity, diversity, and inclusion.